MTVA (MetaVia) OCF Yield %: -206.52 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MTVA MetaVia Inc MTVA
30 GF Score
Price $1.42
! 1 Warning Sign
View Full Analysis

What is MetaVia OCF Yield %?

MetaVia MTVA -1.39% 30 OCF Yield % is -206.52 as of Aug. 01, 2026. GuruFocus rates MTVA with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 1,409 Biotechnology companies, MetaVia ranks worse than 94.54% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, MetaVia's Trailing 12-Month Cash Flow from Operations is $-15.14 Mil, and Market Cap is $7.33 Mil. Therefore, MetaVia's OCF Yield % for today is -206.52%.

The historical rank and industry rank for MetaVia's OCF Yield % or its related term are showing as below:

MTVA' s OCF Yield % Range Over the Past 10 Years
Min: -206.52   Med: 0   Max: -206.52
Current: -206.52


During the past 12 years, the highest OCF Yield % of MetaVia was -206.52%. The lowest was -206.52%. And the median was %.

MTVA's OCF Yield % is ranked worse than
94.54% of 1409 companies
in the Biotechnology industry
Industry Median: -8.79 vs MTVA: -206.52

MetaVia's OCF Margin % for the quarter that ended in Mar. 2026 was %.


MetaVia OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


MetaVia OCF Yield % Related Terms


MetaVia OCF Yield % Historical Data

* Premium members only.

The historical data trend for MetaVia's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MetaVia OCF Yield % Chart

MetaVia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -46.99 -64.18 -59.55 -140.97 -80.79

MetaVia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -144.47 -78.95 -51.93 -100.03 -274.85

MTVA vs CNSP, TRAW, APRE: OCF Yield % Comparison

For the Biotechnology subindustry, MetaVia's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MetaVia OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MetaVia's OCF Yield % distribution charts can be found below:

* The bar in red indicates where MetaVia's OCF Yield % falls into.


MTVA
30GF Score
MetaVia Inc MTVA
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MetaVia OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

MetaVia's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-15.701 / 19.43336
=-80.79%

MetaVia's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-4.258 * 4 / 6.1968
=-274.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -206.52 mean?
MetaVia (MTVA) has a OCF Yield % of -206.52 as of Aug. 01, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on MetaVia and its competitors. According to the industry distribution chart, MetaVia ranks #1332 out of 1409 companies in the Biotechnology industry, placing it in the top 94.5%.
Is MetaVia's OCF Yield % too high?
MetaVia's current OCF Yield % is -206.52. Based on the distribution chart, MetaVia ranks #1332 out of 1409 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, MetaVia has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does MetaVia's OCF Yield % compare to CNSP and TRAW?
According to the Biotechnology industry distribution chart, MetaVia ranks #1332 out of 1409 companies for OCF Yield %. This places MetaVia in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on MetaVia and its competitors. MetaVia's current OCF Yield % is -206.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetaVia stock overvalued right now?
MetaVia (MTVA) has a current OCF Yield % of -206.52. The current OCF Yield % is -206.52. MetaVia's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For MetaVia (MTVA), the current OCF Yield % is -206.52 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MetaVia Business Description

Address 545 Concord Avenue, Suite 210, Cambridge, MA, USA, 02138
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. Vanoglipel (DA-1241) is a novel GPR119 (GPR119) agonist with development optionality as a standalone or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). Agonism of GPR119 in the gut promotes the release of key gut peptides, glucagon-like peptide-1 (GLP-1), glucagon-dependent insulinotropic polypeptide receptor (GIP), and peptide YY.
30GF Score

Get the complete analysis for MTVA

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.42
Price